ArticleAnnals of the rheumatic diseases2021

Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops

Sara Monti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.